Treating bile acid diarrhoea with liraglutide

Affiliations

¹ Department of Gastroenterology, Imperial College Healthcare NHS Trust and Division of Digestive Diseases, Imperial College London, Hammersmith Hospital, London W12 0NN, UK. Electronic address: julian.walters@imperial.ac.uk.

Comment

Julian R F Walters. Lancet Gastroenterol Hepatol. 2022 Oct.

. 2022 Oct;7(10):897-899.

doi: 10.1016/S2468-1253(22)00213-8. Epub 2022 Jul 20.

¹ Department of Gastroenterology, Imperial College Healthcare NHS Trust and Division of Digestive Diseases, Imperial College London, Hammersmith Hospital, London W12 0NN, UK. Electronic address: julian.walters@imperial.ac.uk.

No abstract available

Comment on

Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial.
Kårhus ML, Brønden A, Forman JL, Haaber A, Knudsen E, Langholz E, Dragsted LO, Hansen SH, Krakauer M, Vilsbøll T, Sonne DP, Knop FK. Kårhus ML, et al. Lancet Gastroenterol Hepatol. 2022 Oct;7(10):922-931. doi: 10.1016/S2468-1253(22)00198-4. Epub 2022 Jul 20. Lancet Gastroenterol Hepatol. 2022. PMID: 35868334 Clinical Trial.